HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of patients with gastric cancer and duodenal invasion.

Abstract
We retrospectively examined clinicopathologic features of gastric cancer with duodenal invasion to clarify the effect of surgical treatment that include pancreaticoduodenectomy (PD). Among 2504 patients with gastric cancer, 69 (2.8%) who had gastric cancer and duodenal invasion resected by surgical treatment were investigated. The mode of the duodenal invasion was grouped into three categories: mucosal type, submucosal type, and nodal type. Mucosal type is invasion of the duodenal mucosal layer, submucosal type is invasion of the submucosal layer or deeper, and nodal type is invasion from nodal metastatic lesions around the pancreatic head. The 5-year survival rates of curative PD and curative gastrectomy were 37.3% and 33.8%, respectively. Despite the incidence of adjacent tissue infiltration and significantly higher duodenal invasion average length in cases with PD than in cases with gastrectomy, there was no significant difference in the survival curves. However, the prognoses of the cases with nodal-type invasion were significantly poorer, and all these patients died within 2 years, regardless of whether curative PD had been performed. Curative PD improves the prognosis of cases with long duodenal invasion or pancreas infiltration except for nodal-type duodenal invasion.
AuthorsH Ajisaka, H Fujita, M Kaji, K Maeda, K Yabushita, K Konishi, A Uchiyama, A Miwa
JournalInternational surgery (Int Surg) 2001 Jan-Mar Vol. 86 Issue 1 Pg. 9-13 ISSN: 0020-8868 [Print] Italy
PMID11890346 (Publication Type: Journal Article)
Topics
  • Chi-Square Distribution
  • Duodenal Neoplasms (secondary, surgery)
  • Gastrectomy
  • Humans
  • Neoplasm Invasiveness
  • Pancreaticoduodenectomy
  • Proportional Hazards Models
  • Retrospective Studies
  • Statistics, Nonparametric
  • Stomach Neoplasms (pathology, surgery)
  • Survival Rate
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: